The New York Times reports on a privately owned database containing information on DNA mutations that increase cancer risk and a corresponding grassroots project aimed at making that data public. Owned, built and kept private by Myriad Genetics, the database contains millions of tests on genetic mutations—data to which several researchers want access. The project, Sharing Clinical Reports, asks cancer clinics and doctors around the country to share all Myriad data they have from patient tests, and, according to the report, none of the data contains patient identifiers. On Monday, the Supreme Court will also hear a case that may determine whether two patents of genes owned by Myriad are legal. (Registration may be required to access this story.)
If you want to comment on this post, you need to login.